ORCID
- David Sheridan: 0000-0001-5100-814X
DOI Link
Publication Date
2019-01-01
Publication Title
The Lancet
ISSN
0140-6736
Acceptance Date
2019-11-16
Deposit Date
2024-06-04
Embargo Period
2020-06-12
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Recommended Citation
Younossi, Z., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P., Sheridan, D., Sheikh, M., Trotter, J., Knapple, W., Lawitz, E., Abdelmalek, M., Kowdley, K., Montano-Loza, A., Boursier, J., Mathurin, P., Bugianesi, E., Mazzella, G., Olveira, A., Cortez-Pinto, H., Graupera, I., Orr, D., Gluud, L., Dufour, J., Shapiro, D., Shapiro, D., Zaru, L., MacConell, L., Shringarpure, R., Harrison, S., Sanyal, A., Abdelmalek, M., Abrams, G., Aguilar, H., Ahmed, A., Aigner, E., Aithal, G., Ala, A., Alazawi, W., Albillos, A., Allison, M., Al-Shamma, S., Andrade, R., Andreone, P., Angelico, M., Ankoma-Sey, V., Anstee, Q., Anty, R., Araya, V., Arenas, R., Arkkila, P., Arora, M., Asselah, T., Au, J., Ayonrinde, O., Bailey, R., Balakrishnan, M., Bambha, K., Bansal, M., Barritt, S., Bate, J., Beato, J., Beckebaum, S., Behari, J., Bellot, P., Ben, A., Bennett, M., Berenguer, M., Beretta-Piccoli, B., Berg, T., Bonacini, M., Bonet, L., Borg, B., Bourliere, M., Boursier, J., Bowman, W., Bradley, D., Brankovic, M., Braun, M., Bronowicki, J., Bruno, S., Bugianesi, E., Cai, C., & Calleja, P. (2019) 'Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial', The Lancet, . Available at: 10.1016/s0140-6736(19)33041-7
Additional Files
Younossi (Lancet 2019 Resub Appendix) REGENERATE IA (24Oct2019)FInal Submitted.pdf (735 kB)
